We studied the effects of sustained subtoxic doses of ouabain on left ventricular myocardial monovalent cation active transport and contractility in open-chest dogs. Using a serial biopsy technique, fullthickness left ventricular myocardial samples were obtained prior to and 1 and 2 hours after ouabain infusion, according to a loading dose and infusion schedule demonstrated to produce stable plasma and left ventricular myocardial ouabain concentrations. Ouabain-inhibitable uptake of the potassium analogue 86 Rb + was measured in vitro in these biopsy samples and compared with transport activity in biopsies taken prior to ouabain administration and values in biopsies from dogs receiving vehicle alone. Left ventricular maximum dP/dt increased above baseline values by 29 ± 3 = % (SKM) and 46 ± 9% in ouabain-treated dogs at the 1-and 2-hour biopsy times, respectively, and active transport of 86 Rb + was significantly reduced by 21 ± 6% at 1 hour and 33 ± 5% at 2 hours. Continuous ECG monitoring did not show any arrhythmias. Control dogs receiving vehicle alone had unchanged values for contractility and monovalent cation transport. In another group of dogs, significant inhibition of active ""Rb + transport was demonstrated at the time a sustained ouabain-induced positive inotropic effect was first clearly demonstrable (30 minutes). In contrast, norepinephrine in doses sufficient to produce comparable increases in dP/dt for 30-120 minutes did not change active 80 Rb + transport. These results demonstrate that subtoxic doses of ouabain sufficient to induce a positive inotropic effect are associated with significant reduction of myocardial monovalent cation active transport in a cardiac glycoside-sensitive species. Although a causal relationship cannot be established on the basis of these data, our findings are consistent with the hypothesis that cardiac glycoside-induced inotropy is related to inhibition of myocardial NaK-ATPase-mediated monovalent cation transport.
THE ROLE of altered monovalent cation transport in causing the therapeutic and toxic effects of cardiac glycosides has been studied extensively and debated widely over the past 2 decades.'" 5 It is now generally agreed that toxic doses of cardiac glycosides are associated with inhibition of sodium-and potassium-activated adenosine triphosphatase (NaK-ATPase) and consequently with reduced transmembrane active transport of Na + and K" 1 ". 6 "" However, subtoxic doses of cardiac glycosides, sufficient to cause an increase in contractility without the eventual development of arrhythmias, have not been reported uniformly to be accompanied by decreased monovalent cation active transport or NaK-ATPase inhibition. 12 " 16 Current theories of the mechanism of inotropic action of digitalis as proposed by Langer, r>t " Schwartz and colleagues, 2 -4 -" and Akera and Brody 3 are critically dependent on the correctness of the inference that some degree of monovalent cation active transport inhibition occurs at positively inotropic but subtoxic doses and plasma and myocardial concentrations of cardiac glycosides. The experiments to be described in this communication were, therefore, designed to approach in the most direct way possible the question of whether and to what extent monovalent cation transport is altered by positively inotropic but subtoxic digitalis doses in the intact animal. Accordingly, we investigated the effects of doses of ouabain sufficient to produce sustained subtoxic plasma and myocardial concentrations on left ventricular contractility and myocardial monovalent cation active transport as reflected by the active uptake of the potassium analogue 86 Rb + .
Methods

Hemodynamic Measurements
Adult mongrel dogs (17-26 kg) of either sex were anesthetized with intravenous pentobarbital (42 mg/kg), maintained at 37°C on a heating blanket, intubated with a cuffed endotracheal tube, and ventilated with 100% oxygen using a Harvard respirator. The chest was opened by a midline sternotomy. Hemodynamic data were recorded continuously on a Hewlett-Packard model 7700 multichannel oscillograph at paper speeds of 0.5-100 mm/sec.
The left ventricular (LV) pressure and maximum rate of change in pressure (dP/dt) were monitored with a Hewlett-Packard model 1280 transducer connected to a 5-cm stiff-walled catheter, which directly punctured the apex of the LV. The fluid-filled system had a natural frequency greater than 200 Hz and a damping ratio of 0.06, as measured at the output of the carrier amplifier. A resistance-capacitance differentiating circuit was used to record dP/dt. Heart rate was maintained constant at baseline values in each experiment by electrically stimulating the right atrial appendage with an American Optical model 2002 pacemaker. Femoral artery pressure was recorded with a short polyethylene intra-arterial catheter connected to a Hewlett-Packard model 1280 transducer. Standard limb leads were applied for continuous electrocardiographic monitoring.
Arterial blood samples were withdrawn from the femoral artery for measurement of initial pH, Po 2 , Pco 2 , hematocrit, and potassium concentrations and, at 5-to 30-minute intervals, for ouabain concentrations as indicated in experimental protocols.
Ki;
Rb* Transport Measurements
When dogs were stable hemodynamically after completion of surgical procedures, and at subsequent times as indicated in individual experimental protocols, pursestring sutures were placed in the LV free wall avoiding major coronary vessels. Using a standard 4-mm i.d. cork borer attached to a hand-held power drill, transmural biopsies weighing approximately 50 mg were obtained. They were rinsed briefly in oxygenated buffer at 30°C, then immediately sliced lengthwise into four to eight strips about 1 mm by I mm in cross-sectional area and 5-20 mm in length, weighing 3-18 mg each.
The LV biopsy samples were placed in physiological buffer containing, in IDM concentrations: KC1, 4.0; NaCl, 120; NaHCO,, 24; MgCl 2 , 2.0; CaCl 2 , 2.5: glucose, 5.6; and Na phosphate buffer, 1.1, adjusted to pH 7.4, and equilibrated with 95% oxygen, 5% CO 2 at 30°C.
After a 5-minute equilibration period, myocardia! samples were transferred to flasks containing the same buffer medium (5-ml final volume) except that the KG concentration was changed to 2.0 HIM and ""RbCI (New England Nuclear) was added to give count rates of 10" dpm per milliliter of medium. Unlabeled RbCI was added to give a final Rb + concentration of 0.1 ITIM. The flasks were gassed with 95% O 2 -5% CO 2 . The tissues were incubated in the presence or absence of ouabain (10~: ! M) for 15 minutes at 30 c C. At the comletion of this incubation, slices were rinsed in four successive beakers containing 300 ml of physiological buffer for 5 seconds each. Cerenkov radiation from individual slices was counted immediately in 1 ml of physiological buffer in a Beckman model LS-133 scintillation counter. Tissue samples then were blotted and weighed. Active Rb + uptake, in nmoles Rb + /mg wet weight tissue per min was calculated as the difference between uptake in the presence and absence of 10~: i M ouabain.
The response of the preparation to various concentrations of ouabain in vitro was determined to assess the sensitivity and precision of the method used. Three dogs were anesthetized with pentobarbital, intubated, and ventilated as described above. Thirty minutes later, multiple left ventricular drill biopsies were obtained from the beating heart. Active uptake of 8 "Rb + was determined as described earlier in the presence of concentrations of ouabain varying from 10~9 to 10" :) M.
Experimental Protocol
Ouabain was given intravenously essentially according to the schedule devised by Rhee et al."' to maintain stable plasma concentrations in the subtoxic range. :i H-Ouabain (New England Nuclear) was added to give a final specific activity of 59.0 Ci/mol in all experiments. After an initial control LV biopsy had been taken and stable hemodynamic conditions recorded for 30 minutes, ouabain in saline was given intravenously in a dose of 30 pig/kg over 2 minutes, to six dogs. A constant intravenous infusion of 0.036 /xg/kg per min of ouabain, including ''H-ouabain as above, immediately followed, using a Harvard Apparatus model 2681 infusion pump. Additional left ventricular biopsies were obtained 1 and 2 hours after the initiation of ouabain infusion. Another control group of six dogs was given saline in the same volume and rate, and LV biopsies were taken at the same times as in the ouabaintreated group.
Plasma samples for determination of ouabain conentration were obtained at 0, 10, 30, 60, 90, and 120 minutes following onset of ouabain infusion.
No dog developed any atrial. atrioventricular junctional or ventricular premature beats, nor did any conduction abnormalities or other electrocardiographic evidence of digitalis toxicity occur during the 2-hour infusion period. Toxicity would not be expected at the doses given or the plasma levels maintained, based on our prior experience. 18 
-'"
To examine the effect of ouabain on monovalent cation active transport at the onset of inotropy, five additional dogs were given ouabain by the dosage schedule outlined previously. Hemodynamic data, arterial blood gases, hematocrit, and serum potassium concentration measurements were made as in other experiments. At the onset of a sustained 26 ± 5% increase in contractility (average 30 minutes after initial ouabain bolus), a left ventricular biopsy was obtained and active s "Rb + uptake measured as described above.
To exclude the possibility that transport inhibition would result nonspecifically from any positively inotropic agent, five dogs received a continuous infusion of norepinephrine (average 0.50 /u.g/kg per min) adjusted to produce a sustained positive inotropic effect similar to that observed in the ouabain-treated group. Heart rate was maintained constant and hemodynamic variables, together with arterial blood gases, serum potassium concentration, and hematocrit determinations, were measured. Left ventricular biopsies were obtained for transport measurements prior to norepinephrine, at the onset of sustained positive inotropy, and after 2 hours of sustained positive inotropy.
Plasma and Tissue Ouabain Determinations
Plasma ouabain content was measured by quantifying :1 H counts. Myocardial samples were digested overnight at 40°C in Soluene (Packard Instrument Corp.), followed by VOL. 42, No. 6, JUNE 1978 addition of glacial acetic acid (40 /xl/ml of Soluene) to reduce chemiluminescence. Quenching was corrected by the use of internal standards for both plasma and myocardial samples. Samples were counted until stable count rates wee obtained, using a Packard model 3300 scintillation counter with appropriate windows and correction for 8ti Rb + spill into the :l H channel. Data were analyzed by paired Mest, each dog serving as its own control, and differences in paired values were considered significant when P values were less than 0.05.
Results
Uptake of si; Rb' by Myocardial Samples as a Function of Time
Initial experiments demonstrated that active uptake of 8li Rb + by canine myocardial samples was linear at 30°C over the 15-minute incubation period employed, as illustrated in Figure 1 . Active wi Rb + uptake averaged 0.200 ± 0.010 nmoles Rb + /mg wet weight tissue per 15 minutes (n = 8). Tissue exposed to 10" 3 M ouabain showed no further wl Rb + accumulation after 10 minutes. Active uptake remained linear for at least 30 minutes, after which some deviation from linearity was usually observed at 60 minutes, as shown in Figure 1 .
Concentration-Effect Curve for Ouabain Inhibition of 8(i
Rb + Transport
The active transport of sli Rb + by myocardial biopsy samples as a function of concentration of ouabain is shown in Figure 2 . Tissue samples were incubated for 15 minutes at 30°C. The assay system was highly sensitive to ouabain, with 10"" M concentrations significantly reducing 86 Rb + active transport by 5 ± 1%, (P < 0.05) compared to active transport in the absence of ouabain. Half-maximal inhibition occurred at 8 2 10~7 M ouabain. The sigmoid shape of the log concentration-effect curve is similar to results reported in numerous studies of cardiac glycoside inhibition of monovalent cation transport or NaK-ATPase activity (see Schwartz et al. 2 for review).
Experimental Animals
As summarized in Table 1 , there were no significant differences in mean body weight, hematocrit, serum potassium concentration, arterial blood Po 2 , Pco 2 , or pH between control and experimental groups of dogs. Heart rate and mean arterial pressure did not vary significantly from the initial values at any point in the various experimental groups.
Plasma and Myocardial Ouabain Concentration
Serial plasma and myocardial ouabain concentrations are summarized in Figure 3 for dogs receiving the ouabain infusion regimen previously described and intended to establish and sustain positively inotropic but subtoxic ouabain concentrations. The mean plasma ouabain concentration was 6.0 ± 0.4 ng/ml (1.0 x 10" 8 M) at 1 hour and fell slightly to 4.6 ± 0.3 ng/ml (7.7 x 10" 9 M) at 2 hours (P < 0.05) after initial ouabain administration. The 
Effects of Ouabain on Myocardial Contractility
The ouabain infusion regimen used produced readily demonstrable sustained increases in myocardial contractility. As shown in Figure 4 , the maximum rate of change of left ventricular pressure (dP/dt) increased above pre-ouabain control values by an average of 29 ± 3% at 1 hour and 46 ± 9% at 2 hours. Contractility did not change significantly in control dogs, and no evidence of digitalis toxicity occurred in any dog during the course of these experiments.
Effects of Ouabain on Myocardial Active Transport of 8f,Rb+
As shown in Figure 5 , active transport of 8(1 Rb + into myocardium from ouabain-treated dogs was reduced significantly below pre-ouabain control values by 21 ± 6% at 1 hour and by 33 ± 5% at 2 hours. In contrast, control dogs receiving saline infusions showed unchanged 8(i Rb + transport at these times. These results clearly demonstrate, by a direct assay technique, significant reduction of myocardial monovalent cation active transport by sustained positively inotropic but subtoxic cardiac glycoside doses. 
Effects of Ouabain and Norepinephrine on Myocardial 81 Rb + Transport
In the groups of dogs studied at the onset of inotropy, both norepinephrine in low doses (average 0.50 /xg/kg per min) and ouabain (infusion regimen as previously described) produced comparable inotropic responses at 30 minutes. As summarized in Figure 6 , the response to norepinephrine was a 42 ± 13% increase in maximum LV dP/dt, which was not significantly different from the 26 ± 5% increase in response to ouabain. The norepinephrine infusion was adjusted to maintain LV dP/dt at a value similar to that produced by ouabain over a 2-hour interval. As also summarized in Figure 6 , there was no change in 8<i Rb + active transport compared to control values in the norepinephrine-treated group, either at the onset of inotropy (99 ± 4% of control sll Rb + active transport) or after a 2-hour period of sustained positive inotropy (101 ± 5% of control). In contrast, at the time a definite increase in myocardial contractility was first evident after onset of ouabain administration, there was a 31 ± 9% decrease in active 8li Rb + transport (P < 0.05) compared to control values. Thus, the reduction in 8ti Rb + transport observed after ouabain infusion does not appear to be a nonspecific response to an enhanced contractile state.
Discussion
The observation by Calhoun and Harrison 20 in 1931 that cardiac glycosides diminished myocardial K + concentration first suggested that alteration in cardiac monovalent cation balance might underlie at least some of the actions of digitalis. Subsequent studies of effects of cardiac glycosides on myocardial monovalent cation active transport have resulted in conflicting conclusions. Most investigators have reported diminished myocardial potassium uptake in the presence of large and potentially or overtly toxic doses of cardiac glycosides.'' 2 -2I Although some studies have reported nontoxic concentrations of cardiac glycosides to be associated with diminished potassium uptake, 22~' - 4 Tuttle and colleagues 2 ' reported unchanged potassium uptake at subtoxic ouabain doses. Interpretation of the results of some of these studies is further complicated by the use of animals (rabbit, guinea pig) with intermediate sensitivity 9 ' 25 to cardiac glycosides. The voluminous earlier literature regarding cardiac glycoside effects on myocardial monovalent cation balance has been reviewed in detail by Lee and Klaus.' Since the observation by Schatzmann 26 that cardiac glycosides inhibit active transport of monovalent cations across the cell membrane, studies as cited above showing altered myocardial cation balance have been interpreted as reflecting this inhibitory effect of cardiac glycosides on transport. Binding to, and inhibition of, the monovalent cation transport enzyme complex NaK-ATPase has been postulated by a number of workers to be the initial event in the production of the positive inotropic effect of cardiac glycosides, and an impressive body of circumstantial evidence consistent with this hypothesis has accumulated. 2 ' 6 ' 7. K-ii.27 jfojg interpretation has by no means been universal, however, and others have presented evidence suggesting a lack of correlation between NaK-ATPase inhibition and positive inotropy. 12 " 14 Additional recent studies by Rhee et al. 16 did not demonstrate significant inhibition of NaK-ATPase at positively inotropic but subtoxic glycoside doses. Furthermore, Cohen et al. 15 studied sheep Purkinje fibers exposed to concentrations of ouabain thought to be positively inotropic and obtained results consistent with stimulation rather than inhibition of potassium transport using voltage clamp techniques.
The present studies were designed to approach as directly as possible the question of whether and to what extent monovalent cation transport is altered by sustained subtoxic, positively inotropic, and clinically relevant doses of cardiac glycosides. The following criteria were felt to be of particular importance in the design of these studies.
(1) A cardiac glycoside-sensitive species should be studied, i.e., one in which sustained positive inotropic effects result from doses and plasma concentrations comparable to those known to produce therapeutic effects in man. 28 -2il (2) Animals with intact circulation and intact neural pathways should be studied because of pharmacokinetic considerations and the potential importance of neurally mediated cardiac glycoside responses. 30 -3I (3) A cardiac glycoside infusion regimen should be used that would establish and maintain at least quasi-steady state plasma and myocardial drug concentrations during the period of study. (4) Plasma and myocardial glycoside levels should be measured, and there should be no evidence of toxicity accompanying the positive inotropic effect. (5) A sensitive and precise method capable of detecting modest changes in monovalent cation active transport at clinically relevant digitalis concentrations should be used. This method should be as direct as possible to avoid problems in interpretation due to possible dissociation of cardiac glycoside from receptor during preparative procedures. 2 ' ' 4 (6) The method of assessing monovalent cation transport ideally should allow serial measurements in the same animal, permitting each animal to serve as its own control and enhancing the power of statistical correlations. (7) The methods used should allow correlation of ion transport (or some counterpart thereof) with a simultaneous measurement of the contractile state of the intact heart.
The informative study of Grupp and Charles 22 meets most of these criteria, but did not use a steady state infusion regimen, and plasma and myocardial cardenolide levels were not documented. The study of Rhee and coworkers, 16 further commented upon subsequently, carefully defined these items but reported a lack of significant inhibition of myocardial NaK-ATPase at positively inotropic but subtoxic ouabain doses. The methods used in the present study fulfill each of the above-stated criteria. The canine preparation used is comparable to man in digitalis sensitivity. 2 ' 9 The ouabain infusion regimen used maintained subtoxic but positively inotropic plasma and myocardial concentrations, as shown in Figure 3 , and has been shown by Rhee et al. 18 to maintain a positive inotropic state in the canine myocardium with no evidence of toxicity even when sustained for periods up to 5 hours. Examination of transport in vivo was approximated as nearly as possible by assay of transport in serial biopsy samples with intact cellular architecture within 5 minutes of removal from the beating heart. Use of a pentobarbital-anesthetized, open-chest preparation with resulting tachycardia could alter the complex relationships among arrhythmias, inotropy, and monovalent cation transport, but was necessitated by the serial biopsy protocol.
The potassium analogue 86 Rb + has been shown to be similar to K + in its transport properties 32 and has been used as an indicator of NaK-ATPase-dependent coupled ion transport in red cells, 32 " 34 rat brain, 32 guinea pig left atrium, 34 -M and guinea pig ventricular slices. 27 Our assay of monovalent cation active transport in canine myocardium was highly sensitive, demonstrating significant inhibition at 10" u M ouabain, and thus permitted the detection of alterations in active transport caused by clinically relevant doses and plasma concentrations.
The major finding from the experiments reported here was unequivocal reduction in myocardial monovalent cation active transport by sustained positively inotropic but subtoxic doses ofouabain. These data confirm and extend the observations of Ku et al., 27 who demonstrated monovalent cation pump inhibition at positively inotropic concentrations of cardiac glycosides in Langendorff-perfused guinea pig hearts. The increases in left ventricular maximum dP/dt of 29% and 46% and decreases in active 86 Rb + transport of 21% and 33% at the 1-and 2-hour biopsy times, respectively, in the presence of essentially constant mean myocardial ouabain concentrations (168 and 173 ng/g wet weight), are of interest. These progressive changes presumably reflect the fact that myocardial ouabain content, as measured, included nonspecifically bound ouabain as well as drug bound to NaK-ATPase or other cellular receptors. These findings, then, suggest an increase with time in the ratio of specific to nonspecific VOL. 42, No. 6, JUNE 1978 binding. A similar increase in contractility at nearly constant myocardial total ouabain concentrations was shown by Luchi et al. 36 Although the present data cannot be regarded as proving a cause and effect relationship, the association of increasing transport inhibition with increasing inotropy is consistent with the hypothesis that the positive inotropic response to cardiac glycosides is related to monovalent cation active transport inhibition.
Lack of change in active 86 Rb + transport at the onset or after 2 hours of sustained norepinephrine-induced positive inotropy (Fig. 6) indicates that inhibition of transport was not a consequence of the enhanced contractile state. This absence of alteration in 86 Rb + transport by norepinephrine-induced inotropy is consistent with the results of Akera et al. fi who showed that isoproterenol infusion or stellate ganglion stimulation sufficient to cause increased contractility had no effect on canine myocardial NaK-ATPase activity.
Our results do not support the conclusion reached by Rhee et al. 16 who administered ouabain in the same nontoxic doses used in the present study to intact, openchest dogs and achieved similar plasma and myocardial ouabain levels as well as comparable increases in left ventricular contractility. Measuring NaK-ATPase activity in a partially purified myocardial membrane fraction after multiple preparative steps, they found no significant differences in enzyme activity between control and ouabaintreated animals. NaK-ATPase inhibition was shown only when arrhythmogenic doses were given. These authors pointed out that enzyme-glycoside dissociation during preparative steps could not be excluded; we consider this the most likely mechanism accounting for the lack of significant enzyme inhibition at subtoxic drug concentrations. Schwartz et al. u have previously demonstrated that dissociation of cardiac glycosides from NaK-ATPase during preparation for assay can create problems in correlating enzyme inhibition with inotropic effects. Animal-toanimal variation in baseline enzyme activity may also have contributed to the absence of a statistically significant difference between control and ouabain-treated groups in the studies of Rhee et al. 16 Another recent study by Peters et al. 14 
interpreted as
showing a lack of correlation between positive inotropy and myocardial NaK-ATPase inhibition, used isolated atrial muscle from a relatively cardiac glycoside-insensitive species, the guinea pig. A reported stimulation rather than inhibition of NaK-ATPase at 10~9 M cardiac glycoside concentrations could be observed only during the first 2 days after enzyme preparation, and this finding was not correlated with any direct measurement of monovalent cation transport. This study does not meet five of the seven criteria advanced above, and thus is difficult to relate directly to the findings of the present study.
The electrophysiological studies of TenEick and associates 13 showed persistent reduction of resting membrane potential consistent with reduced monovalent cation transport after washout of the positive inotropic effect of strophanthidin-3-bromoacetate from isolated myocardium. Cohen et al. 15 have recently interpreted their volt-age clamp studies of the effects of ouabain on isolated sheep Purkinje fibers as being most consistent with net stimulation rather than inhibition of potassium transport. These studies used isolated tissue preparations and techniques that, while providing information of considerable fundamental interest, do not directly measure monovalent cation active transport.
We cannot exclude the possibility of a transient stimulation of active transport by low concentrations of ouabain in vivo, since our first measurements were made 30 minutes after the start of ouabain infusion. However, in the in vitro concentration-effect study (Fig. 1) , a 15minute exposure to 10"" M ouabain produced significant inhibition of active 86 Rb + transport.
The data presented here clearly demonstrate reduced myocardial monovalent cation active transport during the positive inotropic effect produced by subtoxic digitalis doses in the intact dog. Although a causal relationship cannot be established on the basis of these data, our findings are consistent with the hypothesis that cardiac glycoside-induced inotropy is related to inhibition of myocardial NaK-ATPase-mediated monovalent cation transport.
